Top Wall Street analysts changed outlook on top names. View all changes on analyst ratings page. See what analysts think of these stocks.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Mizuho analyst Joseph Catanzaro downgraded Apogee Therapeutics Inc (NASDAQ:APGE) from Outperform to Neutral and raised the price target from $110 to $135.
Apogee Therapeutics shares closed at $132.88 on Tuesday.
See how other analysts view this stock.
Wall Street analysts changed ratings on top stocks. Check out the complete list on Benzinga's analyst ratings page. AMAT was…
Wall Street analysts changed ratings for PRIM, ZION, and APGE. Check out analysts' views on these stocks. Photo via Shutterstock.
Wall Street analysts change outlook on top names, with downgrades and initiations. See analyst ratings page for complete view.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including…
Top Wall Street analysts changed outlook on top names. ADCT downgraded See analysts' views.
Wall Street analysts changed outlook on top names. See full ratings page for upgrades, downgrades, and initiations. Analysts view…
